Gary H. Gibbons | Academic Influence

Gary H. Gibbons's AcademicInfluence.com Rankings

Gary H. Gibbons

Medical

#505

World Rank

#687

Historical Rank

#197

USA Rank

Cardiology

#92

World Rank

#94

Historical Rank

#11

USA Rank

medical Degrees

Download Badge

Medical

Gary H. Gibbons's Degrees

Doctorate Medicine Harvard University

Why Is Gary H. Gibbons Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Gary H. Gibbons is an American cardiologist and the current director of the National Heart, Lung, and Blood Institute. Early life and education Gibbons was born in Philadelphia, Pennsylvania, the youngest of three children born to schoolteacher parents. He grew up in the Philadelphia neighborhood of Germantown. He has credited his mother for inspiring him to be committed to public health. He received his undergraduate degree from Princeton University in 1978 and later graduated from Harvard Medical School. He then completed his residency and cardiology fellowship at Brigham and Women's Hospital.

(See a Problem?)

Gary H. Gibbons's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The emerging concept of vascular remodeling. (1994) (1580)
Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. (1995) (786)
Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. (1993) (507)
A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. (1995) (481)
Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. (1993) (454)
Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. (1996) (453)
Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II. (1996) (375)
Fluid shear stress induces endothelial transforming growth factor beta-1 transcription and production. Modulation by potassium channel blockade. (1995) (369)
Fluid shear stress differentially modulates expression of genes encoding basic fibroblast growth factor and platelet-derived growth factor B chain in vascular endothelium. (1993) (320)
Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. (1994) (305)
Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease (1998) (291)
Shear Stress Elevates Endothelial cGMP. Role of a Potassium Channel and G Protein Coupling (1993) (274)
Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme. (1994) (217)
Genetic engineering of vein grafts resistant to atherosclerosis. (1995) (216)
Molecular Mechanisms of Vascular Renin‐Angiotensin System in Myointimal Hyperplasia (1991) (213)
Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury. Influence of redox state and cell phenotype. (1999) (202)
Molecular Therapies for Vascular Diseases (1996) (184)
AJC editor's consensus: psoriasis and coronary artery disease. (2008) (169)
Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cells. (1999) (167)
Endothelial function as a determinant of vascular function and structure: a new therapeutic target. (1997) (166)
Regression of atherosclerosis: role of nitric oxide and apoptosis. (1999) (165)
Vascular Biology and Medicine in the 1990s: Scope, Concepts, Potentials, and Perspectives (1993) (159)
Endothelium and Growth Factors in Vascular Remodeling of Hypertension (1991) (157)
Pharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1 and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery. (1994) (155)
Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: an in vitro gene transfer study. (1998) (151)
Determinants of Notch-3 Receptor Expression and Signaling in Vascular Smooth Muscle Cells: Implications in Cell-Cycle Regulation (2002) (147)
Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues. (1999) (131)
Disparities in trends of hospitalization for potentially preventable chronic conditions among African Americans during the 1990s: implications and benchmarks. (2003) (125)
Cell cycle inhibition preserves endothelial function in genetically engineered rabbit vein grafts. (1997) (119)
Endothelial cell apoptosis in capillary network remodeling (1999) (114)
Racial Differences in Arterial Stiffness and Microcirculatory Function Between Black and White Americans (2013) (113)
Vascular remodeling: mechanisms and implications. (1993) (111)
Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute. (2013) (110)
Regulation of vascular smooth muscle cell apoptosis. Modulation of bad by a phosphatidylinositol 3-kinase-dependent pathway. (1999) (108)
Report of the National Heart, Lung, and Blood Institute Working Group on epigenetics and hypertension. (2012) (103)
Novel and effective gene transfer technique for study of vascular renin angiotensin system. (1993) (103)
Interaction of sleep quality and psychosocial stress on obesity in African Americans: the Cardiovascular Health Epidemiology Study (CHES) (2010) (100)
Genetic markers: progress and potential for cardiovascular disease. (2004) (95)
Overexpression of Ref-1 Inhibits Hypoxia and Tumor Necrosis Factor-Induced Endothelial Cell Apoptosis Through Nuclear Factor-&kgr;B—Independent and —Dependent Pathways (2001) (94)
Hyperglycemia Inhibits Vascular Smooth Muscle Cell Apoptosis Through a Protein Kinase C–Dependent Pathway (2000) (94)
Role of transforming growth factor-beta 1 in the cellular growth response to angiotensin II. (1993) (90)
New perspectives in hypertension research. Potentials of vascular biology. (1994) (87)
Cell biology of vascular hypertrophy in systemic hypertension. (1988) (87)
Differences in weight perception among blacks and whites. (2011) (80)
Association Between Depression and Inflammation-Differences by Race and Sex: The META-Health Study (2011) (79)
Autocrine and paracrine effects of atrial natriuretic peptide gene transfer on vascular smooth muscle and endothelial cellular growth. (1994) (72)
Upregulation of glucose metabolism during intimal lesion formation is coupled to the inhibition of vascular smooth muscle cell apoptosis. Role of GSK3beta. (2001) (72)
Gender differences in the association of visceral and subcutaneous adiposity with adiponectin in African Americans: the Jackson Heart Study (2013) (70)
Phosphodiesterase 4D polymorphisms and the risk of cerebral infarction in a biracial population: the Stroke Prevention in Young Women Study. (2006) (68)
Geographic Variations in Cardiovascular Health in the United States: Contributions of State- and Individual-Level Factors (2015) (67)
Differences in systemic oxidative stress based on race and the metabolic syndrome: the Morehouse and Emory Team up to Eliminate Health Disparities (META-Health) study. (2012) (67)
The next steps in developing clinical practice guidelines for prevention. (2013) (67)
National heart, lung, and blood institute (NHLBI) strategic visioning: setting an agenda together for the NHLBI of 2025. (2015) (65)
DNA Microarray Profiling to Identify Angiotensin-Responsive Genes in Vascular Smooth Muscle Cells: Potential Mediators of Vascular Disease (2003) (63)
Role of AP-1 complex in angiotensin II-mediated transforming growth factor-beta expression and growth of smooth muscle cells: using decoy approach against AP-1 binding site. (1998) (63)
Autocrine-paracrine mechanisms of vascular myocytes in systemic hypertension. (1987) (60)
The Association Between Depression and Leptin Is Mediated by Adiposity (2012) (59)
Generation of an adult smooth muscle cell-targeted Cre recombinase mouse model. (2006) (57)
Genetic engineering of human embryonic stem cells with lentiviral vectors. (2005) (54)
Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute. (2013) (54)
Novel in vitro gene transfer method for study of local modulators in vascular smooth muscle cells. (1993) (52)
The pathophysiology of hypertension: the importance of angiotensin II in cardiovascular remodeling. (1998) (51)
Association Between Living in Food Deserts and Cardiovascular Risk (2017) (50)
Interaction of signals influencing renin release. (1984) (47)
Antisense oligodeoxynucleotide inhibition of vascular angiotensin-converting enzyme expression attenuates neointimal formation: evidence for tissue angiotensin-converting enzyme function. (2000) (44)
Cellular and molecular mechanisms of coronary artery restenosis. (1993) (44)
The Effect of Short Term Vitamin D Supplementation on the Inflammatory and Oxidative Mediators of Arterial Stiffness (2014) (42)
Neuregulin-1 Attenuates Neointimal Formation following Vascular Injury and Inhibits the Proliferation of Vascular Smooth Muscle Cells (2007) (41)
Associations of Adiponectin and Leptin with Incident Coronary Heart Disease and Ischemic Stroke in African Americans: The Jackson Heart Study (2013) (40)
Association of Adiponectin With Left Ventricular Mass in Blacks: The Jackson Heart Study (2011) (40)
Social determinants of cardiovascular health among black and white women residing in Stroke Belt and Buckle regions of the South. (2014) (37)
Association of C-Reactive Protein with Surrogate Measures of Insulin Resistance among Nondiabetic US Adults: Findings from National Health and Nutrition Examination Survey 1999–2002 (2007) (36)
Introduction: Vascular Remodeling: Mechanisms and Implications (1993) (33)
Perceived neighborhood problems are associated with shorter telomere length in African American women (2016) (33)
An oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro. (1998) (32)
Fusigenic liposome-mediated DNA transfer into cardiac myocytes. (1996) (32)
A cone-plate apparatus for the in vitro biochemical and molecular analysis of the effect of shear stress on adherent cells (1995) (31)
Genetic models of human vascular disease. (1995) (31)
Obesity and Hypertension in the Time of COVID-19. (2020) (31)
Geography and genography: prediction of continental origin using randomly selected single nucleotide polymorphisms (2007) (31)
National Heart, Lung, and Blood Institute Strategic Visioning: setting an agenda together for the NHLBI of 2025. (2015) (28)
Vasculoprotective and Cardioprotective Mechanisms of Angiotensin‐Converting Enzyme Inhibition: The Homeostatic Balance Between Angiotensin II and Nitric Oxide (1997) (28)
Mechanisms of vascular remodeling in hypertension: role of autocrine-paracrine vasoactive factors. (1995) (27)
Notch: a mastermind of vascular morphogenesis. (2007) (27)
Socioeconomic status discrimination and C-reactive protein in African-American and White adults (2017) (26)
Basic science: Bedrock of progress. (2016) (25)
Association of C-reactive protein with surrogate measures of insulin resistance among nondiabetic US from National Health and Nutrition Examination Survey 1999-2002. (2007) (24)
IGF-I promotes a shift in metabolic flux in vascular smooth muscle cells. (2002) (23)
Comparisons of the Framingham and Pooled Cohort Equation Risk Scores for Detecting Subclinical Vascular Disease in Blacks Versus Whites. (2017) (22)
Circulating MiR-374a-5p is a potential modulator of the inflammatory process in obesity (2018) (21)
Autocrine-paracrine factors and vascular remodeling in hypertension. (1993) (21)
Systemic administration of HVJ viral coat-liposome complex containing human insulin vector decreases glucose level in diabetic mouse: A model of gene therapy. (2000) (20)
Neighborhood social cohesion is associated with lower levels of interleukin-6 in African American women (2019) (20)
Association between Vitamin D and Adiponectin and Its Relationship with Body Mass Index: The META-Health Study (2013) (20)
Future horizons in cardiovascular molecular therapeutics. (1997) (20)
Influence of socioeconomic status on the whole blood transcriptome in African Americans (2017) (19)
Physiology, Genetics, and Cardiovascular Disease: Focus on African Americans (2004) (19)
Molecular Delivery System for Antisense Oligonucleotides: Enhanced Effectiveness of Antisense Oligonucleotides by HVJ-liposome Mediated Transfer (1997) (18)
Generating evidence to inform an update of asthma clinical practice guidelines: Perspectives from the National Heart, Lung, and Blood Institute (2018) (18)
Pathophysiology of experimental renovascular hypertension. (1985) (17)
Genotype-driven identification of a molecular network predictive of advanced coronary calcium in ClinSeq® and Framingham Heart Study cohorts (2017) (17)
Subclinical Vascular Dysfunction Associated with Metabolic Syndrome in African Americans and Whites. (2015) (17)
Historically black medical schools: addressing the minority health professional pipeline and the public mission of care for vulnerable populations. (2009) (16)
COPD National Action Plan: Addressing a Public Health Need Together. (2017) (16)
The next steps in developing clinical practice guidelines for prevention. (2013) (16)
Antisense oligonucleotides directed at cell cycle regulatory genes as strategy for restenosis therapy. (1993) (16)
Renovascular hypertension: an update on pathophysiology, diagnosis and treatment. (1983) (15)
Obstructive sleep apnea risk and leukocyte telomere length in African Americans from the MH-GRID study (2017) (15)
National Heart, Lung, and Blood Institute (NHLBI) strategic visioning: setting an agenda together for the NHLBI of 2025. (2015) (15)
A genetic risk variant for myocardial infarction on chromosome 6p24 is associated with impaired central hemodynamic indexes. (2012) (15)
Cardiovascular Mortality Differences-Place Matters. (2017) (15)
Death receptors, intimal disease, and gene therapy: are therapies that modify cell fate moving too Fas? (2000) (12)
Associations of Apelin, Visfatin, and Urinary 8-Isoprostane With Severe Hypertension in African Americans: The MH-GRID Study. (2016) (12)
Gene therapy with an E2F transcription factor decoy inhibits cell cycle progression in rat anti-Thy 1 glomerulonephritis. (2004) (12)
Associations of adiponectin with individual European ancestry in African Americans: the Jackson Heart Study (2014) (12)
Angiotensin converting enzyme inhibition and vascular hypertrophy in hypertension (2005) (11)
Role of angiotensin in the control of vascular smooth muscle growth (1991) (11)
Elevated Circulating Angiogenic Progenitors and White Blood Cells Are Associated with Hypoxia-Inducible Angiogenic Growth Factors in Children with Sickle Cell Disease (2012) (10)
Conquering Atherosclerotic Cardiovascular Disease - 50 Years of Progress. (2021) (10)
Effect of Meditation on Endothelial Function in Black Americans With Metabolic Syndrome: A Randomized Trial (2013) (10)
ARMC5 Variants and Risk of Hypertension in Blacks: MH‐GRID Study (2019) (9)
Angiotensin‐Converting Enzyme Inhibition and Vascular Structure in Hypertension (1991) (8)
Developing a research agenda for primary prevention of chronic lung diseases--an NHLBI perspective. (2014) (8)
DNA transfer into vascular smooth muscle using fusigenic Sendai virus (HJV)-liposomes (1997) (8)
NHLBI perspectives on the growth of heart, lung, blood and sleep conditions in Africa: global and domestic insights, challenges and opportunities (2015) (8)
Depressive Symptoms and Subclinical Vascular Disease: The Role of Regular Physical Activity. (2016) (8)
Whole-genome transcriptomic insights into protective molecular mechanisms in metabolically healthy obese African Americans (2018) (8)
Cardioprotective mechanisms of ACE inhibition. The angiotensin II-nitric oxide balance. (1997) (7)
NHLBI strategic visioning: setting an agenda together for the NHLBI of 2025. (2015) (7)
Angiotensin as Local Modulating Factor in Ventricular Dysfunction and Failure Due to Coronary Artery Disease (2012) (6)
The National Center on Sleep Disorders Research-progress and promise. (2019) (6)
Accelerating the Science of SCD Therapies-Is a Cure Possible? (2019) (6)
Effectiveness of an intervention to improve the documentation required for diagnosis of metabolic syndrome in clinics serving African-American patients. (2009) (6)
Morehouse Community Physicians Network (CPN) hypertension registry: patterns of care and opportunities for targeted medical education. (2005) (6)
Vascular remodeling in hypertension: role of autocrine-paracrine factors. (1995) (6)
Building on a Legacy of Hypertension Research: Charting Our Future Together. (2017) (6)
A comprehensive cardiovascular disease lifestyle treatment controlled trial among high-risk African Americans (2013) (5)
Association of Childhood Socioeconomic Status with Leukocyte Telomere Length Among African Americans and the Mediating Role of Behavioral and Psychosocial Factors: Results from the GENE-FORECAST Study (2021) (5)
Does hypertension potentiate atherosclerosis via vascular hypertrophy? (1991) (5)
Rationale and design of a placebo controlled randomized trial to assess short term, high-dose oral cholecalciferol on select laboratory and genomic responses in African Americans with hypovitaminosis D. (2018) (4)
Gene therapy for cardiovascular disease. (2002) (4)
Apolipoprotein E-deficient mice created by systemic administration of antisense oligodeoxynucleotides: a new model for lipoprotein metabolism studies. (2002) (4)
Cardioprotective Mechanisms of ACE Inhibition (2012) (4)
An Examination of Child and Adolescent Neurodevelopment Through National Institutes of Health Studies (2020) (3)
Abstract 668: Inhibition of DNA Methyltransferase Inhibits the Ang II-Induced Increase in Blood Pressure, Vascular Remodeling and Target Organ Damage (2007) (3)
ARMC5 variants and risk of hypertension in African Americans: Minority Health-GRID study (2018) (3)
THE ASSOCIATION OF LIVING IN FOOD DESERTS WITH CARDIOVASCULAR RISK FACTORS AND SUBCLINICAL VASCULAR DISEASE (2016) (3)
Abstract 17806: Sleep Quality and Duration are Associated with Higher Levels of Inflammatory Biomarkers: the META-Health Study (2010) (3)
Differential effect of body weight and systolic blood pressure on nitric oxide-dependent vasodilation in normotensive versus hypertensive African American women (2002) (3)
The Working Group Report on Science-Based Categories for Abstracts Submitted to the Annual Scientific Sessions (1998) (2)
Charting Our Future Together: Turning Discovery Science Into Cardiovascular Health. (2017) (2)
Potential gene therapy for glomerulonephritis: Transfection of NFKB decoy inhibited TNF-A induced cytokine and adhesion molecules expression in vivo (1996) (2)
Abstract 16766: Associations Between Neighborhood Characteristics and Inflammation: The Morehouse and Emory Team Up to Eliminate Health Disparities (META-Health) Study (2014) (2)
Pneumonia with an enlarged cardiac silhouette. (1996) (2)
The NIH Climate Change and Health Initiative and Strategic Framework: addressing the threat of climate change to health (2022) (2)
EDUCATION LEVEL IS ASSOCIATED WITH CARDIOVASCULAR RISK FACTORS, SYSTEMIC INFLAMMATION, ARTERIAL STIFFNESS AND OXIDATIVE STRESS (2016) (1)
African Americans Have Worse Arterial Compliance Than Whites, Independent of Risk Factor Burden and Framingham Risk Estimates (2009) (1)
Potential for transcatheter application of antisense oligonucleotides for the treatment of vascular diseases. (1995) (1)
Abstract 10028: Sex-Differences in the Association of Abdominal Visceral Adipose Tissue with Adiponectin and Leptin in African Americans: The Jackson Heart Study (2011) (1)
Molecular Therapies For Vascular Disease: Altering the Balance Between Cell Growth and Cell Death (1999) (1)
Ethnic differences in subclinical vascular function in South Asians, Whites, and African Americans in the United States (2020) (1)
OXIDATIVE STRESS IS ASSOCIATED WITH REDUCED GLOMERULAR FILTRATION RATE IN A POPULATION WITH PRESERVED RENAL FUNCTION: THE META-HEALTH STUDY (2010) (1)
Localization and regulation of an intrarenal renin-angiotensin system (RAS) (1987) (1)
Abstract 1123: Association Between Depression and Inflammation - Differences by Race: The META-Health Study (2009) (0)
Table 1. The Strategic Goals Supporting the NHLBI Mission Encompass Understanding Human Health and Disease, Translating Basic Research into Preventive and Therapeutic Interventions, and Developing a Biomedical Workforce with the Necessary Skills and Tools for HLBS Research (2015) (0)
Spectrum of Vascular Remodeling Stimulus Clinical Example Vascular Response t Pressure t Flow I Flow Injury Chronic hypertension Arteriovenous fistula After stenosis Balloon angioplasty Risk factors (2005) (0)
Whole-genome transcriptomic insights into protective molecular mechanisms in metabolically healthy obese African Americans (2018) (0)
Erratum: (Arteriosclerosis, Thrombosis and Vascular Biology (2006) 26, (e33)) (2006) (0)
Gene Expression Profiling of Human Endothelial Progenitor Cells Differentiated from Peripheral Blood Mononuclear Cells. (2007) (0)
901-90 In Vivo Genetic Engineering of Cardiac Cells: Intracoronary Administration of Antisense (AS) Oligonucleotides (ODN) (1995) (0)
PM041 Lower Income Is Associated With Increased Cardiovascular Risk Factors, Systemic Inflammation, Arterial Stiffness and Oxidative Stress (2016) (0)
Remembering Stephen Schwartz (2020) (0)
Potential gene therapy using e2f decoy approach with hvj-liposome method to glomerulonephritis in rats (1996) (0)
Abstract 17883: Gender Differences in the Association of Poor Sleep Quality with Arterial Stiffness: the META-Health Study (2010) (0)
Prevention of Restenosis: Gene and Other Biologic Strategies (1996) (0)
The Working Group report on Science-Based Categories for Abstracts: submitted to the annual scientific sessions. The Committee on Scientific Sessions Program (CSSP), American Heart Association. (1998) (0)
Abstract 1691: Inverse Association of Adiponectin and Left Ventricular Mass in African Americans; The Jackson Heart Study (2009) (0)
Reply: primary and secondary prevention of chronic obstructive pulmonary disease: where to next? (2014) (0)
RACIAL DIFFERENCES IN DIGITAL REACTIVE HYPEREMIA MEASURED BY PULSE VOLUME AMPLITUDE: THE META-HEALTH STUDY (2011) (0)
Protocol II : Development of an Ex Vivo Model of Apoptosis (1999) (0)
Social Disadvantage, Gene Expression, Stress and Depressive Symptoms (2022) (0)
The Working Group report on Science-Based Categories for Abstracts: Submitted to the annual scientific sessions. American Heart Association. (1998) (0)
Vascular Endothelium (1991) (0)
and Hypertension Report of the National Heart, Lung, and Blood Institute Working Group on Epigenetics (2012) (0)
NHLBI Director Named (2012) (0)
Abstract 17751: Depressive Symptoms are Associated with Arterial Stiffness in Men (2012) (0)
The Working Group report on Science-Based Categories for Abstracts: submitted to the annual Scientific Sessions. The Committee on Scientific Sessions Program (CSSP), American Heart Association. (1998) (0)
The HVJ-Liposome Molecular Delivery System for In Vivo Genetic Engineering (1997) (0)
Therapeutic use of cis-element-fall in vivo (1994) (0)
914-71 High Efficiency Gene Transfer into Atherosclerotic Lesions in Hypercholesterolemic Rabbit Carotid Arteries (1995) (0)
Abstract 2996: Captopril Restores Endothelial Dysfunction Induced by Acute Salt Loading and Angiotensin II Infusion in Healthy Salt-Sensitive African American Men (2008) (0)
VASCULAR REMODELING AND LESION FORMATION IN RESTENOSIS: IMPLICATIONS FOR NITRIC OXIDE BASED THERAPEUTICS (1997) (0)
Keynote speakers: Charting our future together: Turning discovery science into precision health (2017) (0)
Reply: "What if . . . the National Heart, Lung, and Blood Institute Considers Tobacco?" and "Smoking Control Is a Priority to Promote Heart, Lung, Blood, and Sleep Health". (2015) (0)
The working group report on science-based categories for abstracts: submitted to the annual scientific sessions. American Heart Association. (1998) (0)
New insights on renovascular hypertension (1994) (0)
Cardiovascular Gene Therapy: Possibilities and Realities (1995) (0)
A cone-p la te a p p a r a t u s for the in vitro b i ochemi ca l and molecu lar analys is o f the effect o f shear stress on adherent cells (2004) (0)
RECLASSIFICATION OF METABOLIC SYNDROME FROM ADULT TREATMENT PANEL III TO WORLD HEALTH ORGANIZATION CRITERIA IS ASSOCIATED WITH CHANGES IN ARTERIAL STIFFNESS (2012) (0)
Machine learning identifies SNPs predictive of advanced coronary artery calcium in ClinSeq® and Framingham Heart Study cohorts (2017) (0)
The Working Group report of Science-Based Categories for abstracts submitted to the annual Scientific Sessions. The Committee on Scientific Sessions Program (CSSP), American Heart Association. (1998) (0)
Pathophysiology of hypertension. (1995) (0)
Restenosis: Remodeling Versus Intimal Hyperplasia (1996) (0)
Abstract 19742: Effects of a "Health Partner" Intervention on the Metabolic Syndrome (2014) (0)
Abstract 17432: Influence of Smoking on Arterial Stiffness - A Racial Comparison (2011) (0)
Abstract 15467: The Impact of Systolic Blood Pressure on Arterial Stiffness is Exaggerated in Young Prehypertensive Patients (2011) (0)
Use of locally administered Lysine for IMPROVING vascular FUNCTION (1996) (0)
PREDICTION OF RACIAL DIFFERENCES IN SUB-CLINICAL VASCULAR DISEASE IN AFRICAN AMERICANS AND WHITES: COMPARISON OF THE FRAMINGHAM AND THE ATHEROSCLEROTIC CARDIOVASCULAR RISK SCORES (2015) (0)
Abstract 1004: Disruption of Notch Receptor Signaling Promotes Smooth Muscle Cell Differentiation (2006) (0)
MODULATION OF ENDOGENOUS NITRIC 52 o : (2017) (0)
Therapeutic use of cis-element arresters in vivo (1994) (0)
Circulating MiR-374a-5p is a potential modulator of the inflammatory process in obesity (2018) (0)
Abstract 16789: Plasminogen Activator Inhibitor-1 is Predictive of Endothelial Dysfunction Measured as Digital Reactive Hyperemia (2011) (0)

This paper list is powered by the following services:

Other Resources About Gary H. Gibbons

en.wikipedia.org

What Schools Are Affiliated With Gary H. Gibbons?

Gary H. Gibbons is affiliated with the following schools:

Image Attributions

Image Source for Gary H. Gibbons